On May 10, 2023, EnBio Holdings, Inc closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,670 JPY | +1.33% | -0.54% | +18.44% |
Jun. 17 | CRE's Attributable Profit Down Over 99% in Fiscal Nine Months | MT |
Mar. 15 | CRE's Fiscal H1 Attributable Profit Climbs on Higher Net Sales | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,670 JPY | +1.33% | -0.54% | 299M | ||
628 JPY | -1.57% | -4.56% | 32.08M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.44% | 299M | |
+9.49% | 10B | |
+7.33% | 8.05B | |
-14.52% | 2.71B | |
+2.86% | 2.66B | |
-7.17% | 2.01B | |
+17.97% | 795M | |
-18.88% | 690M | |
-5.11% | 651M | |
+6.32% | 531M |
- Stock Market
- Equities
- 3458 Stock
- News CRE, Inc.
- EnBio Holdings, Inc announced that it has received ¥1.056 billion in funding from CRE, Inc.